We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+4.03%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.17B
AUM Growth
+$70.2M
Cap. Flow
+$38.7M
Cap. Flow %
1.78%
Top 10 Hldgs %
18.79%
Holding
1,595
New
173
Increased
909
Reduced
470
Closed
43

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$7.1M
2
WFC icon
Wells Fargo
WFC
+$5.95M
3
BAC icon
Bank of America
BAC
+$5.07M
4
C icon
Citigroup
C
+$3.95M
5
SLB icon
SLB Ltd
SLB
+$2.95M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$8.15M
2
GILD icon
Gilead Sciences
GILD
+$6.99M
3
ABBV icon
AbbVie
ABBV
+$6.95M
4
CELG
Celgene Corp
CELG
+$6.07M
5
BIIB icon
Biogen
BIIB
+$4.86M

Sector Composition

Rank Sector Weight
1 Healthcare 21.67%
2 Technology 17.33%
3 Financials 11.83%
4 Communication Services 8.3%
5 Consumer Discretionary 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WTRG icon
326
Essential Utilities
WTRG
$11.2B
$1.22M 0.06%
40,708
+1,060
+3% +$31.6K
ALE
327
DELISTED
Allete
ALE
$1.22M 0.06%
19,038
+3,956
+26% +$242K
EMR icon
328
Emerson Electric
EMR
$82.9B
$1.22M 0.06%
21,896
+2,803
+15% +$151K
F icon
329
Ford
F
$57.3B
$1.22M 0.06%
100,475
+2,773
+3% +$33.6K
MAN icon
330
ManpowerGroup
MAN
$2.39B
$1.22M 0.06%
13,698
+4,095
+43% +$338K
WAB icon
331
Wabtec
WAB
$51.1B
$1.22M 0.06%
14,631
+1,946
+15% +$160K
BLUE
332
DELISTED
bluebird bio
BLUE
$1.21M 0.06%
1,510
-70
-4% -$55.6K
ACAD icon
333
Acadia Pharmaceuticals
ACAD
$4.25B
$1.2M 0.06%
41,688
-6,166
-13% -$163K
KR icon
334
Kroger
KR
$34.8B
$1.2M 0.06%
34,824
+7,928
+29% +$259K
PBR icon
335
Petrobras
PBR
$121B
$1.2M 0.06%
118,849
-101,636
-46% -$1.09M
GSK icon
336
GSK
GSK
$103B
$1.2M 0.06%
24,956
+2,612
+12% +$129K
AEE icon
337
Ameren
AEE
$31.5B
$1.2M 0.06%
22,835
-4,523
-17% -$224K
ANET icon
338
Arista Networks
ANET
$219B
$1.2M 0.06%
197,760
-24,464
-11% -$137K
STE icon
339
Steris
STE
$20.9B
$1.2M 0.06%
17,745
+4,608
+35% +$313K
IDA icon
340
Idacorp
IDA
$8.23B
$1.2M 0.06%
14,837
+2,121
+17% +$163K
CDK
341
DELISTED
CDK Global, Inc.
CDK
$1.19M 0.05%
19,973
-751
-4% -$43K
ADSK icon
342
Autodesk
ADSK
$44.3B
$1.19M 0.05%
16,051
-808
-5% -$59.5K
AWK icon
343
American Water Works
AWK
$26.3B
$1.19M 0.05%
16,404
-3,590
-18% -$260K
MCK icon
344
McKesson
MCK
$98.5B
$1.18M 0.05%
8,421
+2,181
+35% +$321K
VEEV icon
345
Veeva Systems
VEEV
$30.3B
$1.18M 0.05%
29,035
-954
-3% -$39K
VTR icon
346
Ventas
VTR
$48.9B
$1.18M 0.05%
18,878
-5,701
-23% -$361K
ALNY icon
347
Alnylam Pharmaceuticals
ALNY
$36.3B
$1.18M 0.05%
31,480
-4,984
-14% -$209K
SNPS icon
348
Synopsys
SNPS
$71.5B
$1.18M 0.05%
19,995
-912
-4% -$54.3K
XRAY icon
349
Dentsply Sirona
XRAY
$2.59B
$1.17M 0.05%
20,331
-525
-3% -$31K
MDRX
350
DELISTED
Veradigm Inc. Common Stock
MDRX
$1.17M 0.05%
114,882
+18,193
+19% +$208K

Similar funds

Profund Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, Profund Advisors held 1,595 positions worth $2.17B, up 3.3% from $2.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Profund Advisors's Q4 2016 filing shows 173 new, 909 increased, 470 reduced and 43 closed positions. Its largest new stake was BT Group plc (ADR): 37,067 shares worth $854K. The largest sale was Amgen, an estimated $8.15M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 26% a quarter earlier, followed by Technology and Financials.

  • Profund Advisors's largest Q4 2016 buy was BT Group plc (ADR): 37,067 shares worth $854K.
  • Profund Advisors added most to JPMorgan Chase in Q4 2016, an estimated $7.1M increase.
  • Profund Advisors's biggest Q4 2016 reduction was Amgen, cutting an estimated $8.15M.
  • Profund Advisors fully exited LinkedIn Corporation in Q4 2016, selling an estimated $2.97M.
  • Profund Advisors's ten largest holdings make up 19% of its $2.17B portfolio in Q4 2016.
  • Profund Advisors opened 173 new positions and closed 43 in Q4 2016.
  • Profund Advisors's portfolio value rose 3.3% quarter-over-quarter to $2.17B.

Based on Profund Advisors's 13F filing for Q4 2016, filed 13 Feb 2017.